ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Unum Group

Unum Group (U1NM34)

437.00
0.00
(0.00%)
Cerrado 05 Enero 2:55PM

Su centro para precios en tiempo real, ideas y debates en vivo

Estadísticas y detalles clave

Último Precio
437.00
Postura de Compra
0.00
Postura de Venta
0.00
Volume Operado de la Acción
-
0.00 Rango del Día 0.00
207.48 Rango de 52 semanas 469.95
Capitalización de Mercado [m]
Precio Anterior
437.00
Precio de Apertura
-
Hora
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
18
Acciones en circulación
195,046,000
Rendimiento del Dividendo
1.51%
Ratio Precio/Utilidad
11.10
Beneficio por acción (BPA)
6.58
turnover
12.39B
Beneficio neto
1.28B

Acerca de Unum Group

Sector
Accident & Health Insurance
Industria
Accident & Health Insurance
Sitio web
Sede
Wilmington, Delaware, USA
Fundado
-
Unum Group is listed in the Accident & Health Insurance sector of the Brazil Bovespa Exchange with ticker U1NM34. The last closing price for Unum was R$437. Over the last year, Unum shares have traded in a share price range of R$ 207.48 to R$ 469.95.

Unum currently has 195,046,000 shares in issue. The market capitalisation of Unum is R$85.24 billion. Unum has a price to earnings ratio (PE ratio) of 11.10.

U1NM34 Últimas noticias

No news to show yet.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000DR
4-19.3-4.22967346044456.3456.343713437.74230769DR
126116.2234042553376469.9537518398.71143646DR
26135.2244.8074756445301.78469.95300.84112315.34301136DR
52229.52110.622710623207.48469.95207.4882313.61616078DR
156296.56211.164910282140.44469.95131.09447198.01396123DR
260334.31325.552634142102.69469.9551.31737155.13982251DR

U1NM34 - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Unum?
El precio actual de las acciones de Unum es R$ 437.00
¿Cuántas acciones de Unum están en circulación?
Unum tiene 195,046,000 acciones en circulación
¿Cuál es la capitalización de mercado de Unum?
La capitalización de mercado de Unum es BRL 85.24B
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Unum?
Unum ha negociado en un rango de R$ 207.48 a R$ 469.95 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Unum?
El ratio precio/beneficio de Unum es 11.1
¿Cuál es el ratio de efectivo a ventas de Unum?
El ratio de efectivo a ventas de Unum es 1.15
¿Cuál es la moneda de reporte de Unum?
Unum presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Unum?
El último ingresos anual de Unum es USD 12.39B
¿Cuál es el último beneficio anual de Unum?
El último beneficio anual de Unum es USD 1.28B
¿Cuál es la dirección registrada de Unum?
La dirección registrada de Unum es 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
¿Cuál es la dirección del sitio web de Unum?
La dirección del sitio web de Unum es www.unum.com
¿En qué sector industrial opera Unum?
Unum opera en el sector ACCIDENT & HEALTH INSURANCE

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
AZEV11Azevedo Travassos Sa
R$ 0.28
(47.37%)
42.2k
JFEN3Joao Fortes Engenharia Sa
R$ 2.71
(18.34%)
239.56k
VLID3Valid Solucoes E SV De SEG EM Meios
R$ 25.00
(16.28%)
749.17k
AERI3Aeris Industria E ComerciodeEquipamentos paraGeracaodeEnergiaS.A
R$ 7.94
(13.43%)
935.03k
PINE3Banco Pine SA
R$ 4.94
(12.02%)
13.1k
COCE11Cia Energetica Ceara Coelce
R$ 0.62
(-35.42%)
10.7k
RADL3QRaia Drogasil SA
R$ 21.46
(-11.07%)
138k
AALR3Allianca Saude e Participacoes S.A.
R$ 7.27
(-9.13%)
67.2k
OFSA3Ourofino S.A
R$ 16.01
(-8.83%)
6.9k
FICT3Fictor Alimentos S.A.
R$ 3.03
(-8.18%)
39.3k
POMO4Marcopolo Sa
R$ 7.35
(-4.05%)
24.33M
CMIN3CSN Mineracao S.A
R$ 4.88
(-3.17%)
19.02M
ITUB4Itau Unibanco Holding SA
R$ 29.82
(-2.45%)
14.89M
HAPV3Hapvida Participacoes Investimento SA
R$ 2.10
(-3.23%)
13.92M
PETR3Petroleo Brasileiro S.A. Petrobras
R$ 40.38
(-0.35%)
12.65M
Mr. Bill Mr. Bill 7 minutos hace
https://www.medicinenet.com/what_are_blood_oxygen_levels/article.htm
devil dog 96 devil dog 96 8 minutos hace
Tell everyone why you think they never took the 39 million shares off restriction if they need shares to dump? Why have they not taken 1 share off restriction since early 2021 if they need shares to dump?? Why would they issue new shares that will be unregistered and also have to wait a year before
ATMH
CrossFireTrader CrossFireTrader 8 minutos hace
Page 22 of 26, and If say I'm Bullish that'll set 280e off, and I'll  be accused of pumping our little lottery ticket. I'm here for the long haul. I'm not here to sell at 0.016 or 0.02 or 0.03 or whatever his new price is. He actually likes GDVM a lot more than he lets on. Since you seem to be somew
GDVM
Mr. Bill Mr. Bill 12 minutos hace
https://measuringmyhealth.com/what-is-a-normal-pi-on-a-pulse-oximeter/
georgejjl georgejjl 12 minutos hace
That is WRONG. The current standard of care is donepezil (Aricept) and memantine, etc.

MAB's still are an extremely small number of treatments for Alzheimer's in the USA and worldwide.

Good luck and GOD bless,
AVXL
axelvento axelvento 33 minutos hace
Q1 the first interim analysis of the vaccine’s efficacy is expected

Moderna’s mRNA-1647
Cytomegalovirus
MRNA
MightyX MightyX 36 minutos hace
Yet no one is innocent
TPTW
BIG D 4 BIG D 4 36 minutos hace
WOW !! HAPPY NEW YEAR TO ALL THE LONGS HERE !! I HAVE 2 NAYSAYERS ON IGNORE SO I NEVER READ THEIR BS !! GO SAVING GRACE-- JJ AND ALL THE NEW POSTERS WHO ARE POSITIVE !! .02 CENTS TO START THE RUN TO ONE DOLLAR IS WHERE WE SHOULD BE !! THIS STOCK IS SUCH A GREAT BUY HERE !! I AM LOADED WITH 32 MILLI
MJNA
MightyX MightyX 37 minutos hace
The judicial system legitimizes prosecution
TPTW
jondoeuk jondoeuk 38 minutos hace
A new paper. From it: 'BNT221 was well tolerated across both DLs, with no dose-limiting toxicities of grade 3 or higher attributed to the T cell product observed. Specifically, no cytokine release, immune effector cell-associated neurotoxicity or macrophage activation syndromes were reported. A dose
BNTX
benz280c benz280c 39 minutos hace
Nice to see you are bullish. This quote may round out your knowledge.
"It is worthy to note that a new CUSIP has been approved by the CUSIP Global Services (CGS).
Subsequently, we have submitted a corporation action with FINRA for a Company name change, Ticker Symbol Change and Cusip
GDVM
shajandr shajandr 40 minutos hace
Sorry to read that you're still feeling sick. I posted a week or two ago about 41 bunnies and also some cats and dogs that were rescued from a home in Delaware county, Iowa and that were transferred to the DBQ county animal shelter. I just spoke with DaSqu_w and she went to the animal shelter to see
Lakota-45 Lakota-45 41 minutos hace
Will do, but I doubt they will listen !!!

~ Lol !!!
IONI
boi568 boi568 42 minutos hace
Probably
AVXL
HokieHead HokieHead 44 minutos hace
Wrong..
TWOH
HokieHead HokieHead 44 minutos hace
Get your facts straight, the halt was in the Canadian side as they are reviewing all the disclosures submitted, there’s ZERO issues in the US, it’s a fully reporting SEC company.
TWOH
Lakota-45 Lakota-45 46 minutos hace
I agree with you 'farmI1234 !!!

I'm pretty sure most of the Savvy Investors, that have been paying attention,
have been loading the dips, and .0004's, for a while now.
I know I have, along with fishing down stream.

I doubt any Longs will get caught short,
WDLF
CaptHowdy CaptHowdy 47 minutos hace
RECOMMENDED.... nothing is offical yet, unnecessary twisting of facts to bolster your negative viewpoints. Thats news is two months old
GRLT
axelvento axelvento 48 minutos hace
Cancer vaccines: What’s ahead in 2025

The spotlight is on mRNA-4157 (V940)

https://gulfnews.com/special-reports/cancer-vaccines-whats-ahead-in-2025-1.500010233
MRNA
facts_matter14 facts_matter14 49 minutos hace
Does this sound like a company with 16 products and a 17th on the way?

https://investorshub.advfn.com/uimage/uploads/2024/12/24/mwowsIMG_6034.png








.
SRMX
HomerRomer HomerRomer 49 minutos hace
More testimony videos from trial participants like the Australian news reel of Ern Heaven would be amazing. I would think that most of the people involved 9 years ago in the earlier phase studies have passed on since the average life expectancy is normally between 3-11 years after being diagnosed w
AVXL
CaptHowdy CaptHowdy 50 minutos hace
That's how to make money on the OTC. 🤦🏻‍♂️ Anyone could do it; only if the effort spent discounting the new leadership in place along with the turn around story underway was used to turn a profit vs. using 9yr old DD to bad mouth new CEO.
GRLT
crescentmotor crescentmotor 50 minutos hace
I think that is a bad precedent to start.

100% on parading a handful of Blarcamesine patients at the JPM conference. I highly doubt AVXL would involve itself with anecdotal gimmicks where there is no way possible to extrapolate isolated successes to meaningful conclusions about broad
AVXL JPM